Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Koninklijke Philips NVRYLPF 74 Piotroski F-Score is 7 as of Aug. 08, 2026, which is 75% above its 10-year median of 4.00. GuruFocus rates RYLPF with a GF Score™ of 74/100 and a GF Value™ of $26.08 (Fairly Valued). The stock has 2 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 92.49% on this metric.
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Koninklijke Philips NV has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Koninklijke Philips NV's Piotroski F-Score or its related term are showing as below:
RYLPF'
s Piotroski F-Score Range Over the Past 10 Years
Min: 1 Med: 4 Max: 7
Current: 7
During the past 13 years, the highest Piotroski F-Score of Koninklijke Philips NV was 7. The lowest was 1. And the median was 4.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Koninklijke Philips NV Piotroski F-Score Related Terms
Koninklijke Philips NV Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Koninklijke Philips NV's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RYLPF vs ABT, SYK, MDT: Piotroski F-Score Comparison
For the Medical Devices subindustry, Koninklijke Philips NV's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 215.962 + 462.529 + 174.566 + 442.396 = $1,295 Mil. Cash Flow from Operations was 383.803 + 1628.806 + 217.341 + 433.18 = $2,663 Mil. Revenue was 5049.296 + 5969.555 + 4514.451 + 5023.041 = $20,556 Mil. Gross Profit was 2242.958 + 2679.157 + 2041.618 + 2476.959 = $9,441 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(30425.606 + 30914.319 + 31550.351 + 31521.387 + 30761.521) / 5 = $31034.6368 Mil. Total Assets at the begining of this year (Jun25) was $30,426 Mil. Long-Term Debt & Capital Lease Obligation was $7,276 Mil. Total Current Assets was $10,749 Mil. Total Current Liabilities was $8,552 Mil.
Net Income was 200.888 + -350.785 + 82.162 + 276.817 = $209 Mil.
Revenue was 4857.936 + 5281.675 + 4429.189 + 5003.46 = $19,572 Mil. Gross Profit was 2226.415 + 2055.497 + 1998.919 + 2319.493 = $8,600 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(31726.588 + 0 + 30341.361 + 29369.73 + 30425.606) / 5 = $30465.82125 Mil. Total Assets at the begining of last year (Jun24) was $31,727 Mil. Long-Term Debt & Capital Lease Obligation was $8,284 Mil. Total Current Assets was $10,453 Mil. Total Current Liabilities was $8,306 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Koninklijke Philips NV's current Net Income (TTM) was 1,295.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Koninklijke Philips NV's current Cash Flow from Operations (TTM) was 2,663.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Koninklijke Philips NV's return on assets of this year was 0.04257772. Koninklijke Philips NV's return on assets of last year was 0.00659012.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Koninklijke Philips NV's gearing of this year was 0.23446377. Koninklijke Philips NV's gearing of last year was 0.27190263.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Koninklijke Philips NV's current ratio of this year was 1.25690427. Koninklijke Philips NV's current ratio of last year was 1.25857512.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Koninklijke Philips NV's number of shares in issue this year was 968.574. Koninklijke Philips NV's number of shares in issue last year was 956.676.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Koninklijke Philips NV's gross margin of this year was 0.45925931. Koninklijke Philips NV's gross margin of last year was 0.43941395.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Koninklijke Philips NV's asset turnover of this year was 0.67562641. Koninklijke Philips NV's asset turnover of last year was 0.61690403.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
0
+
0
+
1
+
1
=
7
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Koninklijke Philips NV has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Koninklijke Philips NV (RYLPF) has a Piotroski F-Score of 7 as of Aug. 08, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Koninklijke Philips NV and its competitors. This is 75% above median its historical median of 4.00. Over the past decade, Koninklijke Philips NV's Piotroski F-Score has ranged from 1.00 to 7.00. According to the industry distribution chart, Koninklijke Philips NV ranks #60 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 7.5%.
Is Koninklijke Philips NV's Piotroski F-Score too high?
Koninklijke Philips NV's current Piotroski F-Score of 7 is 75% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Koninklijke Philips NV's value of 7 is 40% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #60 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Koninklijke Philips NV has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #60 out of 799 companies for Piotroski F-Score. This places Koninklijke Philips NV in the top 8% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Koninklijke Philips NV's value of 7 is 40% above this benchmark. Historically, Koninklijke Philips NV's own Piotroski F-Score has ranged from 1.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Koninklijke Philips NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current Piotroski F-Score is 7, which is 75% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $26.08, compared to a current price of $26.42 — trading 1.3% above its estimated fair value. The current Piotroski F-Score is 7, which is 75% above median its 10-year median of 4.00 and 40% above the Medical Devices & Instruments industry median of 5.00. Koninklijke Philips NV's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Piotroski F-Score is 7 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $26.42 is trading 1.3% above its estimated GF Value™ of $26.08.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
Piotroski F-Score: 7 (75% above median its 10-year median of 4.00)
GF Value™: $26.08 vs. price of $26.42 (1.3% above fair value)
Industry Position: 40% above the Medical Devices & Instruments median (#60 of 799)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
74GF Score
Get the complete analysis for RYLPF
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
